RecruitingPhase 3NCT07816367
A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Sponsor: Kallyope Inc.
Norfolk, NE · Omaha, NE · +70 more sites
Clinical trials in Norfolk, NE
6 recruiting studies have a site in or near Norfolk, NE, Nebraska.
Top conditions here
- Lung Cancer (2)
- Colorectal Cancer (1)
- Heart Failure (1)
- Hypertension (1)
- Leukemia (1)
- Migraine (1)
- Prostate Cancer (1)
- Breast Cancer (1)
All conditions
- Alzheimer's Disease
- Asthma
- Breast Cancer
- COPD
- Crohn's Disease
- Depression
- Type 1 Diabetes
- Type 2 Diabetes
- Heart Failure
- Hypertension
- Leukemia
- Lung Cancer
- Lupus
- Migraine
- Multiple Sclerosis
- Obesity
- Parkinson's Disease
- Prostate Cancer
- Psoriasis
- Rheumatoid Arthritis
- Schizophrenia
- Sickle Cell Disease
- Ulcerative Colitis
- Colorectal Cancer
Showing 6 of 6 studies
RecruitingPhase 3NCT06742723
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Sponsor: AstraZeneca
Norfolk, NE · +132 more sites
RecruitingPhase 3NCT06677060
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Sponsor: AstraZeneca
Norfolk, NE · Omaha, NE · +196 more sites
RecruitingPhase not listedNCT02012699
Integrated Cancer Repository for Cancer Research
Sponsor: University of Nebraska
Hastings, NE · Norfolk, NE · North Platte, NE · +39 more sites
RecruitingPhase 2 / Phase 3NCT03851445
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Sponsor: SWOG Cancer Research Network
Grand Island, NE · Kearney, NE · Lincoln, NE · +1226 more sites
RecruitingPhase 2NCT07546929
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
Sponsor: Housey Healthcare ULC
Norfolk, NE · +24 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.